Tasco Holdings (fka THII)

[JJdivini]

COMPANY SPOTLIGHT - THII

Tasco Holdings International (OTCBB:THII),

a biotechnology company focused on stem cell cryogenics and disposable stem cell
/ tissue transfer instruments


*************

Why is there such controversy surrounding stem cells?

When stem cells are taken from an embryo, the embryo is destroyed. That's
abhorrent to people who consider an embryo to be developing human life.
President Bush has restricted federal money for research into embryonic stem
cells.

The big news last week was that scientists have discovered a way to create human
stem cells by taking one cell from the embryo without destroying the embryo.

While this is incredible news, it certainly will not end all of the controversy.

The Vatican just came out today and said that this new method of making stem
cells is manipulation of the embryo and does not address ethical concerns.

http://news.yahoo.com/s/nm/20060826/ts_nm/religion_stemcell_dc_1

THII doesn't use embryonic stem cells.
THII uses adult stem cells from fat.

Reprogrammable Cells From Fat Are True Adult Stem Cells
http://www.sciencedaily.com/releases/2004/03/040309074344.htm

"Adult" stem cells, are different from the controversial embryonic stem cells.
Some who oppose research into embryonic stem cells, champion the cause of adult
stem cells.

Scientist report that introducing only four genes to adult cells is sufficient
to convert them to something that looks and acts remarkably like an embryonic
stem cell. This may allow the production of an essentially unlimited supply of
stem cells.

Fat has "certainly been overlooked as a potential source of stem cells," says
Dr. Adam Katz, a plastic surgeon who studies the fat-derived cells at the
University of Virginia. Actually, it's probably the most practical source, he
said.

There's good evidence the fat-derived cells can morph into bone, cartilage,
skeletal muscle, blood vessel tissue and fat, at least in the laboratory, with
suggestive evidence they can also turn into heart muscle and nerve cells.

Dr. Kai Pinkernell, a cardiovascular researcher at Tulane University, says he
found an encouraging result in pigs that were given experimental heart attacks.
When he took fat-derived cells from the pigs and put them into the hearts of the
same donor animals, those hearts began to work better.

In fact, they worked just as well as hearts that received stem cells from
marrow, the gold standard for this kind of experiment, he said.

Thii is not in the dream stage anymore. They are about a month away from being
able to store adult stem cells. ONE MONTH! Their 15,000 sq. ft. facility is
almost complete.

They have received and installed a new state-of-the-art CBS Isothermal liquid
nitrogen vapor storage tank and a K Series cryo-storage tank for stem cell
storage.This is an important step toward establishing the Company's Good
Manufacturing Practices (cGMPs) and Good Tissue Practices (cGTP) quality
systems.

The Stem cell industry is experiencing increasing costs to comply with new FDA,
cGMPs, cGTP stem cell requirements. These costs are reducing the number of
competitors, increasing the barriers to entry and better positioning THII as the
leader in the stem cell storage industry.

This is one of the most exciting discoveries ever in my opinion. I don't
believe there is a person on earth that won't benefit sometime in their life
from lifesaving stem cells. Imagine being able to have a minor procedure and
then being able to store your life saving cells that may just save your life in
the future?

THII HIGHLIGHTS

1.) First year revenues to exceed $1 million. Management anticipates continued
surge in year over year revenue growth.

2.) THII receives analyst coverage from Beacon Equity Research with price target
of $6.00. THII currently priced at $2.00.

3.) Float confirmed at 2.7 million with Shares Outstanding at 12.7 million.

4.) Bio-Matrix Scientific focuses on developing leading research and technology
that is patent protected for the purpose of product licensing, which leads to a
continuous revenue stream for the company.

5.) As the market shifts towards disposable tissue management instruments, the
Company believes this will result in over $84 million annually in potential
revenue.

6.) Bio-Matrix Scientific received and installed a new state-of-the-art CBS
Isothermal liquid nitrogen vapor storage tank and a K Series cryo-storage tank
for stem cell storage.This is an important step toward establishing the
Company's Good Manufacturing Practices (cGMPs) and Good Tissue Practices (cGTP)
quality systems. Stem cell industry experiencing increasing costs to comply with
new FDA, cGMPs, cGTP stem cell requirements. These costs are reducing the number
of competitors, increasing the barriers to entry and better positioning THII as
the leader in the stem cell storage industry.